Shanghai Henlius Biotech Co. Ltd.

Industry

  • Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Large Molecule
      • Antibodies

Other Names/Subsidiaries

  • Fosun Pharma
  • Henlius Biopharmaceuticals
  • Shanghai Henlius Biotech, Inc.
  • Taiwan Henlix Biotech Co., Ltd.
  • Hengenix Biotech
See more in Biomedtracker

Latest on Shanghai Henlius Biotech Co. Ltd.

Scrip

Asia Deal Watch: JCR And Alexion Build Upon Existing Gene Therapy Alliances

 
• By Joseph Haas, Lisa Takagi, Sushmita Panda, and Anju Ghangurde

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. JCR Adds $825m Gene Therapy Tech D

Generics Bulletin

Pertuzumab Leader Henlius Receives EU Accreditation For Production Lines

 
• By Dean Rudge

Shanghai Henlius Biotech has opened the door potentially for faster commercialization of a pair of key biosimilars in Europe, after receiving European Medicines Agency good manufacturing practice cert

Scrip

Henlius CEO Details PD-L1 ADC’s Path To 1L Mono/Combo Therapy

 
• By Dexter Jie Yan

As its PD-L1-targeting antibody-drug conjugate (ADC) candidate HLX43 moves into a global-first Phase II trial in China and the US, Shanghai Henlius Biotech sees in the study a launchpad to lift the ag

Scrip

Asia Deal Watch: Lilly Partners With Rznomics On Hearing Loss

 
• By Joseph Haas, Xu Hu, Anju Ghangurde, and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Rznomics To Partner With Lilly On